This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Diabetes Remove Insurance Coverage and Processing Remove Pharmaceutical Companies Related Topics
Generic Medicine Drug Pricing Pharmaceutical Companies Biosimilars Drug Development More Related Topics >
article thumbnail

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

STAT

MARCH 26, 2024

Novo Nordisk plans to seek coverage by Germany’s public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the extended indication wins European approval , Reuters notes. Meanwhile, the Biosecure Act, designed to reduce U.S.

Drug Pricing 210
Drug Pricing Insurance Coverage and Processing Diabetes Pharmaceutical Companies 210
article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

SEPTEMBER 6, 2023

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes.

Insurance Coverage and Processing 59
Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 33,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024